https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-25 / Blood 2006 Mar;107(5):1963-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-25 / Blood 2006 Mar;107(5):1963-92005-10-25 00:00:002019-02-15 09:15:16Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-24 / Gynecol Oncol 2006 Mar;100(3):469-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-24 / Gynecol Oncol 2006 Mar;100(3):469-782005-10-24 00:00:002023-01-23 10:35:21HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-13 / J. Clin. Invest. 2005 Nov;115(11):3265-75
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-13 / J. Clin. Invest. 2005 Nov;115(11):3265-752005-10-13 00:00:002019-02-15 09:15:19Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-07 / Hum. Immunol. 2005 Sep;66(9):938-49
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-07 / Hum. Immunol. 2005 Sep;66(9):938-492005-10-07 00:00:002019-02-15 09:25:40Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-03 / Br. J. Cancer 2005 Oct;93(7):749-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-03 / Br. J. Cancer 2005 Oct;93(7):749-562005-10-03 00:00:002019-02-15 09:24:20Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Mol. Carcinog. 2005 Oct;44(2):111-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Mol. Carcinog. 2005 Oct;44(2):111-212005-10-01 00:00:002019-02-15 08:35:09A mechanism of hyperthermia-induced apoptosis in ras-transformed lung cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-812005-10-01 00:00:002019-02-15 08:37:44Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Expert Opin Biol Ther 2005 Oct;5(10):1303-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Expert Opin Biol Ther 2005 Oct;5(10):1303-152005-10-01 00:00:002019-02-15 08:44:45Natural killer-dendritic cell cross-talk in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-732005-10-01 00:00:002019-02-15 09:03:11Administration of dendritic cells in cancer nodules in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Zhonghua Xue Ye Xue Za Zhi 2005 Oct;26(10):593-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Zhonghua Xue Ye Xue Za Zhi 2005 Oct;26(10):593-72005-10-01 00:00:002019-02-15 08:51:02[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
